Revvity
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
What If You Bought RVTY Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jun 4, 2001 | $35.02 | 2-for-1 | 2× | 16× |
| May 11, 1992 | — | 2-for-1 | 2× | 8× |
| Feb 2, 1982 | — | 2-for-1 | 2× | 4× |
| Feb 4, 1980 | — | 2-for-1 | 2× | 2× |
Revvity Market Cap Timeline
Validated annual market-cap history is available from 2023. Split markers cover all 4 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.